← Back to Search

Traditional Chinese Medicine

Xuanfei Baidu Granules for Coronavirus

Phase 2
Waitlist Available
Led By Darcy V Spicer, MD
Research Sponsored by Darcy Spicer
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days
Awards & highlights

Study Summary

This study is evaluating whether a traditional Chinese medicine may help individuals with chronic obstructive pulmonary disease.

Eligible Conditions
  • Coronavirus

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility of recruitment
Participation Rate
Rate of hospitalization or death
+1 more
Secondary outcome measures
Adverse Events
COVID-19 testing compliance
Grade 3 and 4 adverse events
+5 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: XFBD ArmExperimental Treatment1 Intervention
XFBD (administered as 1 packet of granules dissolved in warm water) orally twice daily for 14 day, 1 hour after food in the morning and at night with at least 8 hours in between doses
Group II: Placebo ArmPlacebo Group1 Intervention
Placebo (administered as 1 packet of granules dissolved in warm water) orally twice daily for 14 day, 1 hour after food in the morning and at night with at least 8 hours in between doses

Find a Location

Who is running the clinical trial?

Darcy SpicerLead Sponsor
Darcy V Spicer, MDPrincipal InvestigatorKeck Medicine of USC
1 Previous Clinical Trials
10 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Pilot Trial of XFBD, a TCM, in Persons With COVID-19
Darcy Spicer 2021. "Pilot Trial of XFBD, a TCM, in Persons With COVID-19". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04810689.
~1 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top